14.62
price up icon5.64%   0.78
after-market Handel nachbörslich: 14.33 -0.29 -1.98%
loading

Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
7.29%
42.61
45.96 40.43 38.11 34.75
Operating Income/Loss
7.29%
-42.61
-45.96 -40.43 -38.11 -34.75
Income/Loss From Continuing Operations Before Tax
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Income/Loss From Continuing Operations After Tax
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Net Income/Loss
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.31%
104.94
95.13 93.81 93.52 87.57
Diluted Average Shares
10.31%
104.94
95.13 93.81 93.52 87.57
Basic Earnings Per Share
20.93%
-0.34
-0.43 -0.36 -0.34 -0.33
Diluted Earnings Per Share
20.93%
-0.34
-0.43 -0.36 -0.34 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.31
price down icon 1.55%
$86.53
price up icon 0.38%
$26.01
price up icon 0.54%
$110.77
price down icon 0.48%
$132.60
price up icon 2.43%
biotechnology ONC
$313.97
price up icon 1.50%
Kapitalisierung:     |  Volumen (24h):